A Cluster Randomized Trial to Assess the Impact of Patient and Provider Education on Use of Home Dialysis
Patient and Provider Education for Patients With Severe Chronic Kidney Disease: Assessing the Impact on Barriers and Use of Home Dialysis
1 other identifier
interventional
55
1 country
2
Brief Summary
Patients with severe kidney failure require dialysis or transplantation to survive. For those in whom a transplant is not an option, there are two main dialysis options: hemodialysis (either incenter or at home) or home peritoneal dialysis. Home-based therapies (peritoneal and home hemodialysis) are under-utilized in many Canadian jurisdictions with the proportion of home-based therapies varying between 10 and 40% across centres. Studies show that the low use of home dialysis is due to a variety of factors, though patient and provider awareness and knowledge of home dialysis are major factors. In this cluster randomized trial, the investigators will determine whether a standardized modality education program directed at patients, in combination with a provider-directed intervention, can increase the use of home dialysis in incident dialysis patients in Canada.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2014
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2014
CompletedFirst Posted
Study publicly available on registry
July 28, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedOctober 10, 2018
October 1, 2018
3.2 years
July 11, 2014
October 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary Efficacy Outcome: Use of home dialysis
Proportion of patients with incident end-stage renal disease initiating dialysis after the intervention who are using home dialysis (home hemodialysis or peritoneal dialysis) six months after dialysis initiation. Use of home dialysis will be ascertained from the clinic clusters and confirmed by linkage with the Canadian Organ Replacement Register (CORR).
Use of home dialysis at six months after dialysis initiation
Secondary Outcomes (1)
Secondary outcome: Use of home dialysis at six months in patients who have been followed by a Nephrologist
Use of home dialysis at six months after dialysis initiation in patients who have been followed by a Nephrologist
Study Arms (2)
Active KT Intervention
EXPERIMENTALCKD clinics receiving the active knowledge translation intervention.
Usual standard of care
NO INTERVENTIONClinics will continue their standard of care education and approach to use of home dialysis.
Interventions
1. Provider \& patient-directed infographics educating patients about home dialysis will be displayed in prominent clinic wall space 2. Educational white board presentations promoting home dialysis 3. Each clinic will receive reports outlining their current use of home dialysis in incident ESRD patients compared with provincial \& national averages 4. A Canadian version of the MATCH D tool will be provided to clinic staff, to help evaluate patient appropriateness for home dialysis. 5. Each clinic will receive an in-person visit from one of the study investigators/collaborators detailing the benefits of home dialysis, and the educational tools being offered to support care within their clinic.
Eligibility Criteria
You may qualify if:
- Multidisciplinary clinics in Canada that provide care coordinated by a Nephrologist to patients with chronic kidney disease (CKD). These clinics have already been identified in a previous survey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- University of Manitobacollaborator
Study Sites (2)
University of Calgary
Calgary, Alberta, T2N 4Z6, Canada
University of Manitoba
Winnipeg, Manitoba, R3T 2N2, Canada
Related Publications (1)
Manns BJ, Garg AX, Sood MM, Ferguson T, Kim SJ, Naimark D, Nesrallah GE, Soroka SD, Beaulieu M, Dixon SN, Alam A, Allu S, Tangri N. Multifaceted Intervention to Increase the Use of Home Dialysis: A Cluster Randomized Controlled Trial. Clin J Am Soc Nephrol. 2022 Apr;17(4):535-545. doi: 10.2215/CJN.13191021. Epub 2022 Mar 21.
PMID: 35314481DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Navdeep Tangri, MD PhD FRCPC
University of Manitoba
- PRINCIPAL INVESTIGATOR
Braden Manns, MD
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 11, 2014
First Posted
July 28, 2014
Study Start
September 1, 2014
Primary Completion
November 1, 2017
Study Completion
September 1, 2018
Last Updated
October 10, 2018
Record last verified: 2018-10